Other Clinical Trial - Guideline Recommended Care & Excess Mortality for

See also
Status	Clinical Trial	Phase
Completed	`NCT02600962` - Impact of Initial Diagnosis on Mortality for Patients Hospitalised With Acute Myocardial Infarction	N/A
Completed	`NCT02406248` - Brilinta Taiwan Post Approval Safety Study	Phase 4
Completed	`NCT02693015` - Impact of Time to Coronary Angiography on Survival for NSTEMI	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT02600962 - Impact of Initial Diagnosis on Mortality for Patients Hospitalised With Acute Myocardial Infarction

N/A

Completed

NCT02406248 - Brilinta Taiwan Post Approval Safety Study

Phase 4

Completed

NCT02693015 - Impact of Time to Coronary Angiography on Survival for NSTEMI

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02436187
Study type	Observational [Patient Registry]
Source	University of Leeds
Contact
Status	Completed
Phase
Start date	January 2003
Completion date	June 2013

Guideline Recommended Care and Excess Mortality for Non ST-elevation Myocardial Infarction : A National Cohort Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms